Kairos Pharma (KAPA) Stock Chart & Stock Price History $0.87 +0.01 (+1.64%) As of 04/25/2025 04:10 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartHeadlinesSEC FilingsBuy This Stock Kairos Pharma Stock Price Performance 5 Day Performance-4.94%1 Month Performance-9.69%3 Month Performance-42.20%6 Month Performance-40.21%Year-To-Date Performance-42.96% Receive KAPA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address KAPA Stock Chart for Saturday, April, 26, 2025 KAPA Chart by TradingView Kairos Pharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2025$0.85$0.87+1.64%$0.89$0.8449,876 shs$11.88 million04/24/2025$0.86$0.85-0.81%$0.88$0.82126,718 shs$11.69 million04/23/2025$0.89$0.86-3.89%$0.89$0.80205,261 shs$11.78 million04/22/2025$0.91$0.89-1.90%$0.94$0.85136,785 shs$12.26 million04/21/2025$0.96$0.91-4.99%$0.97$0.88152,070 shs$12.50 million04/18/2025$0.96$0.96$1.03$0.92316,678 shs$13.15 million04/17/2025$0.91$0.96+5.49%$1.03$0.92316,678 shs$13.15 million04/16/2025$0.98$0.91-7.56%$1.04$0.88108,500 shs$12.47 million04/15/2025$0.95$0.98+3.39%$0.99$0.9342,134 shs$13.49 million04/14/2025$1.01$0.95-5.73%$0.99$0.9363,008 shs$13.04 million Get the Latest News and Ratings for KAPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. 04/11/2025$0.99$1.01+2.02%$1.04$0.9567,405 shs$13.84 million04/10/2025$1.00$0.99-1.00%$1.05$0.9796,213 shs$13.56 million04/09/2025$0.97$1.00+3.35%$1.09$0.94125,711 shs$13.70 million04/09/2025$0.97$1.00+3.35%$1.09$0.94125,711 shs$13.70 million04/08/2025$1.14$0.97-15.12%$1.12$0.95211,615 shs$13.26 million04/08/2025$1.14$0.97-15.12%$1.12$0.95211,615 shs$13.26 million04/07/2025$1.06$1.14+7.55%$1.20$1.01229,464 shs$15.62 million04/04/2025$0.94$1.06+12.77%$1.25$0.98845,913 shs$14.52 million04/03/2025$0.92$0.94+2.34%$1.05$0.9373,209 shs$12.88 million04/02/2025$0.92$0.92-0.16%$0.95$0.9225,042 shs$12.58 million04/01/2025$0.94$0.92-1.73%$0.97$0.9119,163 shs$12.60 million03/31/2025$0.92$0.94+1.61%$1.00$0.9046,166 shs$12.83 million03/28/2025$0.97$0.92-5.01%$0.98$0.9242,207 shs$12.62 million03/27/2025$0.96$0.97+1.04%$0.97$0.9056,373 shs$13.29 million03/26/2025$0.98$0.96-2.03%$1.08$0.92148,415 shs$13.15 million03/25/2025$0.95$0.98+2.93%$1.05$0.9442,880 shs$13.43 million Related Companies Avalo Therapeutics Stock Chart ImmuCell Stock Chart Oncolytics Biotech Stock Chart Skye Bioscience Stock Chart Repare Therapeutics Stock Chart Gain Therapeutics Stock Chart Cue Biopharma Stock Chart Forte Biosciences Stock Chart FSD Pharma Stock Chart PDS Biotechnology Stock Chart Receive KAPA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:KAPA) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kairos Pharma, LTD. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kairos Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KAPA Stock Free KAPA Stock Alerts